Correlation Between Genovis AB and Xvivo Perfusion

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Genovis AB and Xvivo Perfusion at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Genovis AB and Xvivo Perfusion into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Genovis AB and Xvivo Perfusion AB, you can compare the effects of market volatilities on Genovis AB and Xvivo Perfusion and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Genovis AB with a short position of Xvivo Perfusion. Check out your portfolio center. Please also check ongoing floating volatility patterns of Genovis AB and Xvivo Perfusion.

Diversification Opportunities for Genovis AB and Xvivo Perfusion

0.05
  Correlation Coefficient

Significant diversification

The 3 months correlation between Genovis and Xvivo is 0.05. Overlapping area represents the amount of risk that can be diversified away by holding Genovis AB and Xvivo Perfusion AB in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Xvivo Perfusion AB and Genovis AB is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Genovis AB are associated (or correlated) with Xvivo Perfusion. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Xvivo Perfusion AB has no effect on the direction of Genovis AB i.e., Genovis AB and Xvivo Perfusion go up and down completely randomly.

Pair Corralation between Genovis AB and Xvivo Perfusion

Assuming the 90 days trading horizon Genovis AB is expected to under-perform the Xvivo Perfusion. In addition to that, Genovis AB is 1.31 times more volatile than Xvivo Perfusion AB. It trades about -0.02 of its total potential returns per unit of risk. Xvivo Perfusion AB is currently generating about 0.06 per unit of volatility. If you would invest  24,050  in Xvivo Perfusion AB on November 5, 2024 and sell it today you would earn a total of  22,550  from holding Xvivo Perfusion AB or generate 93.76% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Genovis AB  vs.  Xvivo Perfusion AB

 Performance 
       Timeline  
Genovis AB 

Risk-Adjusted Performance

10 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Genovis AB are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively uncertain basic indicators, Genovis AB unveiled solid returns over the last few months and may actually be approaching a breakup point.
Xvivo Perfusion AB 

Risk-Adjusted Performance

2 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Xvivo Perfusion AB are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively stable basic indicators, Xvivo Perfusion is not utilizing all of its potentials. The newest stock price uproar, may contribute to short-horizon losses for the private investors.

Genovis AB and Xvivo Perfusion Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Genovis AB and Xvivo Perfusion

The main advantage of trading using opposite Genovis AB and Xvivo Perfusion positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Genovis AB position performs unexpectedly, Xvivo Perfusion can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Xvivo Perfusion will offset losses from the drop in Xvivo Perfusion's long position.
The idea behind Genovis AB and Xvivo Perfusion AB pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.

Other Complementary Tools

Global Correlations
Find global opportunities by holding instruments from different markets
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
CEOs Directory
Screen CEOs from public companies around the world
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios